Document is current
Any future updates will be listed below
-
Authors
Elia, Josephine
Pajer, Kathleen
Prasad, Raghuram
Pumariega, Andres
Maltenfort, Mitchell
Utidjian, Levon
Shenkman, Elizabeth
Kelleher, Kelly
Rao, Suchitra
Margolis, Peter A.
Christakis, Dimitri A.
Hardan, Antonio Y.
Ballard, Rachel
Forrest, Christopher B.
-
Funding
Funding for this research was provided by:
Patient-Centered Out-comes Research Institute (R1-CRN-2020-0007)
- License Information
-
More Information
Article History
Received: 21 March 2023
Accepted: 20 August 2023
First Online: 14 September 2023
Declarations
:
: The study was approved by the Institutional Review Board at the Children’s Hospital of Philadelphia (IRB protocol #17-014012), exempt from consent and Health Insurance Portability and Accountability Act authorization, and used the PEDSnet Master Reliance Agreement process whereby participating institutions ceded IRB review to the Children’s Hospital of Philadelphia.
: Not applicable. The manuscript includes only de-identified data.
: Drs. Elia, Pajer, Maltenfort, Utidjian, Shenkman, Kelleher, Rao, Margolis, Christakis, Ballard, and Forrest reported no biomedical financial interests or potential conflicts of interest. Dr. Prasad reported past funding by Aevi and the Eagles Autism Foundation and current funding from the PCORI foundation. Dr. Pumariega reported funding for the UF/North Central Florida Pediatric Behavioral Health Collaborative, funded by the Children’s Medical Services, of the Florida department of Health. Dr. Hardan reported being a consultant with Finch Therapeutics, Jazz Pharmaceuticals, IAMA Therapeutics, and Beaming Health.
